loading

Agios Pharmaceuticals Inc Azioni (AGIO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
15.29%
8.189
7.103 7.399 6.712 5.609
Cost Of Revenue
7.00%
0.627
0.586 0.633 1.108 0.554
Gross Profit
16.03%
7.562
6.517 6.766 5.604 5.055
Operating Expenses
11.67%
99.63
112.79 107.66 99.30 95.67
Benefits Costs and Expenses
35.52%
100.26
73.98 108.30 100.41 96.22
Costs And Expenses
11.57%
100.26
113.38 108.30 100.41 96.22
Operating Income/Loss
13.37%
-92.07
-106.28 -100.90 -93.70 -90.61
Income/Loss From Continuing Operations Before Tax
37.67%
-92.07
-66.88 -100.90 -83.81 -81.02
Income/Loss From Continuing Operations After Tax
15.00%
-81.55
-95.94 -91.32 -83.81 -81.02
Net Income/Loss
15.00%
-81.55
-95.94 -91.32 -83.81 -81.02
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
61,373%
56.38
0.0917 55.80 55.60 55.27
Diluted Average Shares
61,373%
56.38
0.0917 55.80 55.60 55.27
Basic Earnings Per Share
15.70%
-1.45
-1.72 -1.64 -1.51 -1.47
Diluted Earnings Per Share
15.70%
-1.45
-1.72 -1.64 -1.51 -1.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):